Leave a message
Sapphire Medical Clinics and Dendrite Clinical Systems have launched the UK Medical Cannabis Registry, an initiative that is designed to rapidly expand the evidence base for medical cannabis in the UK and decrease the cost of access for patients. The launch will collect and analyse clinical information on patients taking medical cannabis treatments for all recognised eligible conditions.
17 June 2020
“I am very pleased to report that demand for the Dendrite Web-Registry platform has reached an all-time high” Dr Peter Walton, Managing Director of Dendrite Clinical System. “We’re receiving new orders for new national and international registries every few days now – for surgical registries, medical registries, rare disease registries, medical device registries and Coronavirus Registries (for a range of Community, National, International and Global Covid-19 Registries).”
21 May 2020
Sapphire Medical Clinics and Dendrite Clinical Systems have established the UK’s first national UK’s first comprehensive medical cannabis patient registry - UK Medical Cannabis Registry. The UK Medical Cannabis Registry will be the first of its kind covering all conditions for which there is evidence of clinical efficacy of medical cannabis. The formation of the registry means that real world evidence, cited as a key barrier to wider patient prescriptions by NHS England, will now be available on request to the medical community for analysis.
5 March 2020
The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), in conjunction with Dendrite Clinical Systems, is delighted to announce the release of the First UK National Flap Registry (UKNFR) Report. The UKNFR, which was launched in August 2015, collects information on all major free and pedicled flap operations carried out in the UK.
20 December 2019
Dendrite Clinical Systems, the publisher of Bariatric News, has announced the publication of the Bariatric News Industry and Product Guide 2019 – a comprehensive A-Z guide to companies, products and services within the bariatric and metabolic specialty.
20 September 2019
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
10 September 2019
Dendrite Clinical Systems is a specialist supplier of clinical database and analysis software and consultancy services for the international healthcare sector. We have a unique and proven track record of delivery based on a deep understanding of professional users needs in an increasingly dynamic health care environment. Our systems are widely used to support:
Dendrite Clinical Systems was established in 1993, by co-directors Dr Peter Walton, Keith Price and Neal McCann, and over the last 24 years has become one of the leading suppliers of clinical software to hospitals and institutions in the world. Since it's inception, the company has maintained a belief that clinical data collection and analysis is crucial in achieving effective clinical audit and ultimately, improving patient outcomes.
Starting from an office in central London, has evolved from a specialist supplier of clinical databases and analysis software, to providing consultancy and publishing services for the international healthcare sector. The company now has two offices in the UK and agents across four continents. The company now has expanded its global user base across thousands of hospitals, more than 170 national and international registries in more than 80 countries.
In the last 24 years, Dendrite has continued to develop innovative clinical software solutions, which have been utilised in many different clinical scenarios, fulfilling the company's ethos of providing the tools for effective clinical governance.
Dendrite Clinical Systems have an impressive client list featuring National and International Medical Societies. We also have an extensive client-base in the medical device and pharmaceutical industry. Our contracts range from simple sponsorship agreements for national and international databases that guarantee maximum exposure to our clients' target audiences to tailored systems that we have developed for a specific product or therapeutic area. A number of our industry clients have used our systems specifically to run post-marketing surveillance studies and to collect reliable market research data.
Real World Evidence is an emerging powerful trend which is becoming a cornerstone of value-based pricing and may redefine the basis of competition and access in the pharmaceutical and medical device industry in the near future.
Real World Evidence goes beyond traditional controlled clinical trials. Pharmaceutical and medical device companies can use Real World Evidence data to inform stakeholders about a product's use, treatment patterns (standards of care), benefits and cost effectiveness to gain and defend market access, inform the design of products and trials and transform their relationships with clinicians from a supplier to a collaborator.
Large scale Real World Evidence data has not been available until recently – this is a major opportunity to demonstrate the value of your products. All of the major pharmaceutical companies have recently initiated Real World Evidence projects to inform product development and/or commercial decisions. Post market research has been the only growing area in the clinical research field in recent years. Indeed, if pharmaceutical and medical device companies do not take the initiative and lead the development of compelling real world cost-effectiveness arguments, regulatory agencies will create their own potentially unfavourable product narratives of which we have seen multiple examples already.
While there may be various sources of real world clinical information (such as Electronic Patient Record systems), implementation experience has proven that this information is mostly sporadic, incomplete and difficult to reconcile and analyse, particularly on a large scale. Clinical registries have proven to be the main source of scientifically robust large scale Real World Evidence to date.
Dendrite Clinical Systems is a global leader in the area of clinical registries with an extensive experience in the field of Real World Evidence studies. Our customer dedication and delivery track record is impeccable. We would be delighted to work with you to help you design and support your Real World Evidence project.
Please contact us to discuss your Real World Evidence project:
Email: rwe@e-dendrite.com
Phone: +44 20 8949 8999 (Dr Alexey Brovko)
We are an international software company led by healthcare professionals and extremely talented and experienced developers.
We also use analytics & advertising services. To opt-out click for more information.
